Bioalpha Holdings Bhd (XKLS:0179) EV-to-EBIT: -0.26 (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Bioalpha Holdings Bhd EV-to-EBIT?

Bioalpha Holdings Bhd XKLS:0179 +50.00% EV-to-EBIT is -0.26 as of Aug. 06, 2026. The stock has 7 warning signs investors should review. Among 1,555 Consumer Packaged Goods companies, Bioalpha Holdings Bhd ranks worse than 64308.62% on this metric.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bioalpha Holdings Bhd's Enterprise Value is RM8.34 Mil. Bioalpha Holdings Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was RM-31.64 Mil. Therefore, Bioalpha Holdings Bhd's EV-to-EBIT for today is -0.26.

The historical rank and industry rank for Bioalpha Holdings Bhd's EV-to-EBIT or its related term are showing as below:

XKLS:0179' s EV-to-EBIT Range Over the Past 10 Years
Min: -85.26   Med: -0.64   Max: 33.9
Current: -0.27

During the past 13 years, the highest EV-to-EBIT of Bioalpha Holdings Bhd was 33.90. The lowest was -85.26. And the median was -0.64.

XKLS:0179's EV-to-EBIT is ranked worse than
100% of 1555 companies
in the Consumer Packaged Goods industry
Industry Median: 12.07 vs XKLS:0179: -0.27

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Bioalpha Holdings Bhd's Enterprise Value for the quarter that ended in Mar. 2026 was RM22.21 Mil. Bioalpha Holdings Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was RM-31.64 Mil. Bioalpha Holdings Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -142.45%.


Bioalpha Holdings Bhd  (XKLS:0179) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Bioalpha Holdings Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2026 ) =EBIT / Enterprise Value (Q: Mar. 2026 )
=-31.639/22.21035
=-142.45 %

Bioalpha Holdings Bhd's Enterprise Value for the quarter that ended in Mar. 2026 was RM22.21 Mil.
Bioalpha Holdings Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-31.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioalpha Holdings Bhd EV-to-EBIT Related Terms


Bioalpha Holdings Bhd EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Bioalpha Holdings Bhd's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioalpha Holdings Bhd EV-to-EBIT Chart

Bioalpha Holdings Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -97.95 -2.46 -3.13 -1.11 -0.90

Bioalpha Holdings Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.76 -0.29 -0.67 -0.90 -0.70

XKLS:0179 vs KHC, GIS: EV-to-EBIT Comparison

For the Packaged Foods subindustry, Bioalpha Holdings Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioalpha Holdings Bhd EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioalpha Holdings Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bioalpha Holdings Bhd's EV-to-EBIT falls into.



Bioalpha Holdings Bhd EV-to-EBIT Calculation

Bioalpha Holdings Bhd's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=8.342/-31.639
=-0.26

Bioalpha Holdings Bhd's current Enterprise Value is RM8.34 Mil.
Bioalpha Holdings Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-31.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -0.26 mean?
Bioalpha Holdings Bhd (XKLS:0179) has a EV-to-EBIT of -0.26 as of Aug. 06, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Bioalpha Holdings Bhd and its competitors. According to the industry distribution chart, Bioalpha Holdings Bhd ranks #999999 out of 1555 companies in the Consumer Packaged Goods industry.
Is Bioalpha Holdings Bhd's EV-to-EBIT too high?
Bioalpha Holdings Bhd's current EV-to-EBIT is -0.26. Based on the distribution chart, Bioalpha Holdings Bhd ranks #999999 out of 1555 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does Bioalpha Holdings Bhd's EV-to-EBIT compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Bioalpha Holdings Bhd ranks #999999 out of 1555 companies for EV-to-EBIT. This places Bioalpha Holdings Bhd in the lower half of its industry. The industry median EV-to-EBIT is 12.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.07, based on 1,555 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Bioalpha Holdings Bhd and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioalpha Holdings Bhd's current EV-to-EBIT is -0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioalpha Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Bioalpha Holdings Bhd (XKLS:0179) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.02 — trading 50% above its estimated fair value. The current EV-to-EBIT is -0.26. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Bioalpha Holdings Bhd (XKLS:0179), the current EV-to-EBIT is -0.26 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioalpha Holdings Bhd Business Description

Address No. 1, Jalan Perindustrian Suntrack, Hub Perindustrian Suntrack, Bandar Baru Bangi, Off Jalan P1A, Seksyen 13, Kajang, SGR, MYS, 43000
Bioalpha Holdings Bhd is a nutraceutical and health supplement group in Malaysia, operates a multi-faceted value chain that includes agricultural development, research and development (R&D), and the manufacturing of functional food and supplement products on an Original Design Manufacturer (ODM) basis. The business operates in segments that include Trading, Manufacturing, Retail pharmacy, and Others. It generates maximum revenue from Manufacturing segment, which involves Research, development, manufacture, importer, exporter, distribution and trader of nutritional and health care products. Geographically, the company derives majority revenue from Malaysia, while it also has its presence in China and Others.